Mark Tristan Quimque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Tristan Quimque has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Allan Patrick Gose Macabeo
Institut fur Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany; School of Criminal Justice Education, Ilocos Sur Polytechnic State College – Main Campus, Candon City, 2710 Ilocos Sur, Philippines
8 shared publications - Jay Carl Agbay
Department of Science and Technology - Philippine Science High School — Central Mindanao Campus, Balo-i 9217, Lanao del Norte, Philippines
3 shared publications - Joe Anthony H. Manzano
College of Science University of Santo Tomas Manila Philippines
3 shared publications - Kin Israel Notarte
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
3 shared publications Adriel M. Pastrana
Faculty of Medicine and Surgery, University of Santo Tomas, España, 1008Manila, Philippines
2 shared publicationsDelfin Yñigo Pilapil
Department of Biological Sciences, College of Science, University of Santo Tomas, España Blvd., Manila 1015, Philippines
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15 (3)
Dihydropyrimidinones as Potential Direct Renin Inhibitors: In Silico Molecular Docking and Molecular Dynamics Approach
This study contributes to ongoing efforts to address the global health challenge of hypertension by in silico exploring new inhibitors of the renin-angiotensin-aldosterone system (RAAS). Renin, a key enzyme regulator in this pathway, was selected as the molecular target for treatment intervention. Specifically, the potential of dihydropyrimidinone (DHPM) derivatives as direct renin inhibitors was investigated using the enzyme’s crystal structure (PDB ID: 2V0Z. A total of 440 compounds with substitutions at N1, N3, and C4 of the DHPM core were evaluated through molecular docking. Top-scoring ligands for each substitution type were further assessed through molecular dynamics simulations. Pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), were predicted using SwissADME, while toxicity risks were assessed with OSIRIS Property Explorer. Compounds 30j and 33h emerged as promising candidates, showing strong binding affinities and favorable pharmacokinetic profiles. Molecular dynamics confirmed the stability of these compounds within the renin complex throughout the simulation period. These results support the potential of DHPM derivatives as lead compounds for the development of new renin-targeted antihypertensive therapies.
- 30 September 2026
- Published by AMG Transcend Association in Letters in Applied NanoBioScience
- Vol. 15 (3)
Open AccessDihydropyrimidinones as Potential Direct Renin Inhibitors: In Silico Molecular Docking and Molecular Dynamics Approach
This study contributes to ongoing efforts to address the global health challenge of hypertension by in silico exploring new inhibitors of the renin-angiotensin-aldosterone system (RAAS). Renin, a key enzyme regulator in this pathway, was selected as the molecular target for treatment intervention. Specifically, the potential of dihydropyrimidinone (DHPM) derivatives as direct renin inhibitors was investigated using the enzyme’s crystal structure (PDB ID: 2V0Z. A total of 440 compounds with substitutions at N1, N3, and C4 of the DHPM core were evaluated through molecular docking. Top-scoring ligands for each substitution type were further assessed through molecular dynamics simulations. Pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), were predicted using SwissADME, while toxicity risks were assessed with OSIRIS Property Explorer. Compounds 30j and 33h emerged as promising candidates, showing strong binding affinities and favorable pharmacokinetic profiles. Molecular dynamics confirmed the stability of these compounds within the renin complex throughout the simulation period. These results support the potential of DHPM derivatives as lead compounds for the development of new renin-targeted antihypertensive therapies.
- 31 December 2025
- Published by Philippine-American Academy of Science and Engineering in SciEnggJ
- Vol. 18 (Supplement) , 515-538
Philippine marine natural product scaffolds as inhibitors of DNA damage response pathways with promising binding propensity, stability, and pharmacokinetic profiles
Since identifying effective compounds is time-consuming and costly, computational drug-discovery methods now enable high-throughput screening of bioactive molecules. Philippine marine natural products (MNPs) were computationally screened against four targets in the DNA damage response (DDR) pathways: Poly (ADP-ribose) polymerase 1 (PARP-1), Histone Deacetylase 2 (HDAC2), and topoisomerases I and II (TOPOI and TOPOII). These targets are crucial in various diseases, including cancer. A total of 27 MNPs were screened through molecular docking. Most favorable complexes were further analyzed for pharmacokinetic and drug-likeness profiling, visualization and molecular interaction analysis, and molecular dynamics (MD) simulations. Several MNPs demonstrated strong binding affinities to DDR targets, along with promising pharmacokinetic profiles supporting their drug candidacy including Ningalin B for PARP-1; Perophoramidine for HDAC2; Ulithiacyclamide B for TOPOI; and Patellamide C for TOPOII. MD simulations affirmed the stability of the best complexes via root-mean-square deviation and fluctuation, radius of gyration, and interaction energy analyses. Overall, the in silico results highlight the potential of Philippine MNPs—especially Ningalin B, Perophoramidine, Ulithiacyclamide B, and Patellamide C—as natural-product inhibitors of DDR pathways relevant to anticancer drug discovery.
- 31 December 2025
- Published by Philippine-American Academy of Science and Engineering in SciEnggJ
- Vol. 18 (Supplement) , 515-538
Philippine marine natural product scaffolds as inhibitors of DNA damage response pathways with promising binding propensity, stability, and pharmacokinetic profiles
Since identifying effective compounds is time-consuming and costly, computational drug-discovery methods now enable high-throughput screening of bioactive molecules. Philippine marine natural products (MNPs) were computationally screened against four targets in the DNA damage response (DDR) pathways: Poly (ADP-ribose) polymerase 1 (PARP-1), Histone Deacetylase 2 (HDAC2), and topoisomerases I and II (TOPOI and TOPOII). These targets are crucial in various diseases, including cancer. A total of 27 MNPs were screened through molecular docking. Most favorable complexes were further analyzed for pharmacokinetic and drug-likeness profiling, visualization and molecular interaction analysis, and molecular dynamics (MD) simulations. Several MNPs demonstrated strong binding affinities to DDR targets, along with promising pharmacokinetic profiles supporting their drug candidacy including Ningalin B for PARP-1; Perophoramidine for HDAC2; Ulithiacyclamide B for TOPOI; and Patellamide C for TOPOII. MD simulations affirmed the stability of the best complexes via root-mean-square deviation and fluctuation, radius of gyration, and interaction energy analyses. Overall, the in silico results highlight the potential of Philippine MNPs—especially Ningalin B, Perophoramidine, Ulithiacyclamide B, and Patellamide C—as natural-product inhibitors of DDR pathways relevant to anticancer drug discovery.
- 6 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2743-2758
Multitargeting Inhibitory Activity of Moringa oleifera Natural Plant Product Scaffolds against Proteins Implicated in Chronic Myeloid Leukemia: Insights from Molecular Docking, Molecular Dynamics and ADMET Predictions
Chronic myeloid leukemia (CML) remains among the most prevalent hematologic malignancies in many developing countries. The disease accounts for 15% of all newly diagnosed adult leukemias in the world. Although tyrosine kinase inhibitors offer effective disease control, therapeutic accessibility and long-term efficacy remain major challenges in local clinical settings. Moringa oleifera, a widely consumed vegetable, is known for its rich profile of phytochemicals with reported cytotoxic, antioxidant and anticancer properties. This study applied integrative computational modeling approaches to predict the inhibitory potential of 91 secondary metabolites from M. oleifera against key regulatory proteins implicated in CML progression: breakpoint cluster region-Abelson tyrosine kinase (BCR-ABL1), c-Src kinase, and fms-like tyrosine kinase 3 (FLT3). Using docking simulations, lycopene (16) exhibited strong predicted affinity for BCR-ABL1 (binding energy or BE [ ] –9.9 kcal/mol), while [ ]-carotene (6) showed the highest binding potential to c-Src (BE [ ] –11.0 kcal/mol) and FLT3 (BE [ ] –11.7 kcal/mol). Subsequent molecular dynamics simulations affirmed the thermodynamic stability of these ligand–target complexes, suggesting sustained interaction under physiological conditions. The majority of top-binding ligands were also predicted to have favorable drug-likeness, and pharmacokinetic and toxicity profiles. These findings underscore the potential of M. oleifera as a valuable source of lead compounds for CML drug discovery and exemplify the utility of integrative computational approaches in identifying functionally relevant natural products, especially in resource-limited settings.
- 6 December 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2743-2758
Multitargeting Inhibitory Activity of Moringa oleifera Natural Plant Product Scaffolds against Proteins Implicated in Chronic Myeloid Leukemia: Insights from Molecular Docking, Molecular Dynamics and ADMET Predictions
Chronic myeloid leukemia (CML) remains among the most prevalent hematologic malignancies in many developing countries. The disease accounts for 15% of all newly diagnosed adult leukemias in the world. Although tyrosine kinase inhibitors offer effective disease control, therapeutic accessibility and long-term efficacy remain major challenges in local clinical settings. Moringa oleifera, a widely consumed vegetable, is known for its rich profile of phytochemicals with reported cytotoxic, antioxidant and anticancer properties. This study applied integrative computational modeling approaches to predict the inhibitory potential of 91 secondary metabolites from M. oleifera against key regulatory proteins implicated in CML progression: breakpoint cluster region-Abelson tyrosine kinase (BCR-ABL1), c-Src kinase, and fms-like tyrosine kinase 3 (FLT3). Using docking simulations, lycopene (16) exhibited strong predicted affinity for BCR-ABL1 (binding energy or BE [ ] –9.9 kcal/mol), while [ ]-carotene (6) showed the highest binding potential to c-Src (BE [ ] –11.0 kcal/mol) and FLT3 (BE [ ] –11.7 kcal/mol). Subsequent molecular dynamics simulations affirmed the thermodynamic stability of these ligand–target complexes, suggesting sustained interaction under physiological conditions. The majority of top-binding ligands were also predicted to have favorable drug-likeness, and pharmacokinetic and toxicity profiles. These findings underscore the potential of M. oleifera as a valuable source of lead compounds for CML drug discovery and exemplify the utility of integrative computational approaches in identifying functionally relevant natural products, especially in resource-limited settings.
- 1 March 2023
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 26 (3) , 459-488
Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review
: The ongoing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has been proven to be more severe than the previous coronavirus outbreaks due to the virus’ high transmissibility. With the emergence of new variants, this global phenomenon took a more dramatic turn, with many countries recently experiencing higher surges of confirmed cases and deaths. On top of this, the inadequacy of effective treatment options for COVID-19 aggravated the problem. As a way to address the unavailability of target-specific viral therapeutics, computational strategies have been employed to hasten and systematize the search. The objective of this review is to provide initial data highlighting the utility of polyphenols as potential prophylaxis or treatment for COVID-19. In particular, presented here are virtually screened polyphenolic compounds which showed potential as either antagonists to viral entry and host cell recognition through binding with various receptor-binding regions of SARS-CoV-2 spike protein or as inhibitors of viral replication and post-translational modifications through binding with essential SARS-CoV-2 non-structural proteins.
- 1 March 2023
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 26 (3) , 459-488
Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review
: The ongoing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has been proven to be more severe than the previous coronavirus outbreaks due to the virus’ high transmissibility. With the emergence of new variants, this global phenomenon took a more dramatic turn, with many countries recently experiencing higher surges of confirmed cases and deaths. On top of this, the inadequacy of effective treatment options for COVID-19 aggravated the problem. As a way to address the unavailability of target-specific viral therapeutics, computational strategies have been employed to hasten and systematize the search. The objective of this review is to provide initial data highlighting the utility of polyphenols as potential prophylaxis or treatment for COVID-19. In particular, presented here are virtually screened polyphenolic compounds which showed potential as either antagonists to viral entry and host cell recognition through binding with various receptor-binding regions of SARS-CoV-2 spike protein or as inhibitors of viral replication and post-translational modifications through binding with essential SARS-CoV-2 non-structural proteins.
- Open Access
- 31 January 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (6) , 5377-5392
Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba
Pathologic hyperreactive inflammatory responses occur when there is excessive activation of a proinflammatory NF-κB pathway and a reduced cytoprotective NRF2 cascade. The noncytotoxic, highly selective COX-2 inhibitory flavonol-enriched butanol fraction (UaB) from Uvaria alba (U. alba) was investigated for its inflammatory modulating potential by targeting NF-κB activation and NRF2 activity. Enzyme-linked immunosorbent assay was initially performed to measure levels of proinflammatory mediators [nitric oxide (NO), prostaglandin E2, and reactive oxygen species (ROS)] and cytokines [tumor necrosis factor-alpha (TNF-α), IL-1β, and IL-6], followed by reverse transcription-polymerase chain reaction and western blotting to determine mRNA and protein expression, respectively. Using immunofluorescence staining combined with western blot analysis, the activation of NF-κB was further investigated. NRF2 activity was also measured using a luciferase reporter assay. UaB abrogated protein and mRNA expressions of inducible nitric oxide synthase (iNOS), COX-2, TNF-α, IL-1β, and IL-6 in RAW 264.7 macrophages, thereby suppressing the production of proinflammatory mediators and cytokines. This was further validated when a concentration-dependent decrease in NO and ROS production was observed in zebrafish (Danio rerio) larvae. UaB also increased NRF2 activity in HaCaT/ARE cell line and attenuated NF-κB activation by inhibiting the nuclear translocation of transcription factor p65 in RAW 264.7 macrophages. Nontargeted LC-MS analysis of UaB revealed the presence of the flavonols quercitrin (1), quercetin (2), rutin (3), kaempferol (4), and kaempferol 3-O-rutinoside (5). Molecular docking indicates that major flavonol aglycones have high affinity toward COX-2 NSAID-binding sites, TNF-α, and TNF-α converting enzyme, while the glycosylated flavonoids showed strong binding toward iNOS and IKK-all possessing dynamic stability when performing molecular dynamics simulations at 140 ns. This is the first report to have elucidated the mechanistic anti-inflammatory potential of the Philippine endemic plant U. alba.
- 31 January 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (6) , 5377-5392
Open AccessAttenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba
Pathologic hyperreactive inflammatory responses occur when there is excessive activation of a proinflammatory NF-κB pathway and a reduced cytoprotective NRF2 cascade. The noncytotoxic, highly selective COX-2 inhibitory flavonol-enriched butanol fraction (UaB) from Uvaria alba (U. alba) was investigated for its inflammatory modulating potential by targeting NF-κB activation and NRF2 activity. Enzyme-linked immunosorbent assay was initially performed to measure levels of proinflammatory mediators [nitric oxide (NO), prostaglandin E2, and reactive oxygen species (ROS)] and cytokines [tumor necrosis factor-alpha (TNF-α), IL-1β, and IL-6], followed by reverse transcription-polymerase chain reaction and western blotting to determine mRNA and protein expression, respectively. Using immunofluorescence staining combined with western blot analysis, the activation of NF-κB was further investigated. NRF2 activity was also measured using a luciferase reporter assay. UaB abrogated protein and mRNA expressions of inducible nitric oxide synthase (iNOS), COX-2, TNF-α, IL-1β, and IL-6 in RAW 264.7 macrophages, thereby suppressing the production of proinflammatory mediators and cytokines. This was further validated when a concentration-dependent decrease in NO and ROS production was observed in zebrafish (Danio rerio) larvae. UaB also increased NRF2 activity in HaCaT/ARE cell line and attenuated NF-κB activation by inhibiting the nuclear translocation of transcription factor p65 in RAW 264.7 macrophages. Nontargeted LC-MS analysis of UaB revealed the presence of the flavonols quercitrin (1), quercetin (2), rutin (3), kaempferol (4), and kaempferol 3-O-rutinoside (5). Molecular docking indicates that major flavonol aglycones have high affinity toward COX-2 NSAID-binding sites, TNF-α, and TNF-α converting enzyme, while the glycosylated flavonoids showed strong binding toward iNOS and IKK-all possessing dynamic stability when performing molecular dynamics simulations at 140 ns. This is the first report to have elucidated the mechanistic anti-inflammatory potential of the Philippine endemic plant U. alba.
- Open Access
- 7 October 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (41) , 36856-36864
Polyoxygenated Cyclohexenes from Uvaria grandiflora with Multi-Enzyme Targeting Properties Relevant in Type 2 Diabetes and Obesity
Shikimic acid-derived polyoxygenated cyclohexene natural products commonly occurring in several species of the Uvaria represent natural products with promising biological activities. While a number of derivatives have been reported from Uvaria grandiflora (U. grandiflora), further studies are needed to discover additional bioactive congeners, particularly derivatives with multi-protein target inhibitory properties implicated in diseases such as diabetes and obesity. In this paper, isolation and identification of a new highly oxygenated cyclohexene, uvagrandol (1), along with the known compound (-)-zeylenone (2) from the DCM sub-extract of U. grandiflora following in vitro and in silico assessment of their enzyme inhibitory properties against α-glucosidase, dipeptidyl peptidase IV, porcine lipase, and human recombinant monoacylglycerol lipase are reported. The structure of 1 was elucidated using 1D and 2D NMR data analysis. The absolute configuration of 1 was established by quantum chemical calculations via the Gauge-Independent Atomic Orbital (GIAO) NMR method followed by TDDFT-Electronic Circular Dichroism (ECD) calculations. The structures of the eight possible stereoisomers were optimized by means of DFT calculations (B3LYP/6-31+G[d,p] in vacuum), and then their isotropic shielding tensors were obtained using the GIAO method at mPW1PW91/6-31G(d,p) in chloroform. Through DP4+, the isomer of configuration (1S,2S,3R,6R) for 1 was predicted with 96.3% probability. Compounds 1 and 2 significantly inhibited the four target enzymes in vitro. Binding studies through molecular docking simulations showed strong binding affinities for (-)-zeylenone (2), thus validating the in vitro results. Our findings suggest the potential of polyoxygenated cyclohexenes, in particular (-)-zeylenone (2), in anti-diabetic and anti-obesity drug discovery.
- 7 October 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (41) , 36856-36864
Open AccessPolyoxygenated Cyclohexenes from Uvaria grandiflora with Multi-Enzyme Targeting Properties Relevant in Type 2 Diabetes and Obesity
Shikimic acid-derived polyoxygenated cyclohexene natural products commonly occurring in several species of the Uvaria represent natural products with promising biological activities. While a number of derivatives have been reported from Uvaria grandiflora (U. grandiflora), further studies are needed to discover additional bioactive congeners, particularly derivatives with multi-protein target inhibitory properties implicated in diseases such as diabetes and obesity. In this paper, isolation and identification of a new highly oxygenated cyclohexene, uvagrandol (1), along with the known compound (-)-zeylenone (2) from the DCM sub-extract of U. grandiflora following in vitro and in silico assessment of their enzyme inhibitory properties against α-glucosidase, dipeptidyl peptidase IV, porcine lipase, and human recombinant monoacylglycerol lipase are reported. The structure of 1 was elucidated using 1D and 2D NMR data analysis. The absolute configuration of 1 was established by quantum chemical calculations via the Gauge-Independent Atomic Orbital (GIAO) NMR method followed by TDDFT-Electronic Circular Dichroism (ECD) calculations. The structures of the eight possible stereoisomers were optimized by means of DFT calculations (B3LYP/6-31+G[d,p] in vacuum), and then their isotropic shielding tensors were obtained using the GIAO method at mPW1PW91/6-31G(d,p) in chloroform. Through DP4+, the isomer of configuration (1S,2S,3R,6R) for 1 was predicted with 96.3% probability. Compounds 1 and 2 significantly inhibited the four target enzymes in vitro. Binding studies through molecular docking simulations showed strong binding affinities for (-)-zeylenone (2), thus validating the in vitro results. Our findings suggest the potential of polyoxygenated cyclohexenes, in particular (-)-zeylenone (2), in anti-diabetic and anti-obesity drug discovery.
- Open Access
- 14 September 2021
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (38) , 24382-24396
Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System
- 14 September 2021
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (38) , 24382-24396
Open AccessComputational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System
- 31 August 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (22) , 12209-12220
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
The severity of the COVID-19 pandemic has necessitated the search for drugs against SARS-CoV-2. In this study, we explored via in silico approaches myxobacterial secondary metabolites against various receptor-binding regions of SARS-CoV-2 spike which are responsible in recognition and attachment to host cell receptors mechanisms, namely ACE2, GRP78, and NRP1. In general, cyclic depsipeptide chondramides conferred high affinities toward the spike RBD, showing strong binding to the known viral hot spots Arg403, Gln493 and Gln498 and better selectivity compared to most host cell receptors studied. Among them, chondramide C3 (1) exhibited a binding energy which remained relatively constant when docked against most of the spike variants. Chondramide C (2) on the other hand exhibited strong affinity against spike variants identified in the United Kingdom (N501Y), South Africa (N501Y, E484K, K417N) and Brazil (N501Y, E484K, K417T). Chondramide C6 (9) showed highest BE towards GRP78 RBD. Molecular dynamics simulations were also performed for chondramides 1 and 2 against SARS-CoV-2 spike RBD of the Wuhan wild-type and the South African variant, respectively, where resulting complexes demonstrated dynamic stability within a 120-ns simulation time. Protein-protein binding experiments using HADDOCK illustrated weaker binding affinity for complexed chondramide ligands in the RBD against the studied host cell receptors. The chondramide derivatives in general possessed favorable pharmacokinetic properties, highlighting their potential as prototypic anti-COVID-19 drugs limiting viral attachment and possibly minimizing viral infection. Communicated by Ramaswamy H. Sarma
- 31 August 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (22) , 12209-12220
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
The severity of the COVID-19 pandemic has necessitated the search for drugs against SARS-CoV-2. In this study, we explored via in silico approaches myxobacterial secondary metabolites against various receptor-binding regions of SARS-CoV-2 spike which are responsible in recognition and attachment to host cell receptors mechanisms, namely ACE2, GRP78, and NRP1. In general, cyclic depsipeptide chondramides conferred high affinities toward the spike RBD, showing strong binding to the known viral hot spots Arg403, Gln493 and Gln498 and better selectivity compared to most host cell receptors studied. Among them, chondramide C3 (1) exhibited a binding energy which remained relatively constant when docked against most of the spike variants. Chondramide C (2) on the other hand exhibited strong affinity against spike variants identified in the United Kingdom (N501Y), South Africa (N501Y, E484K, K417N) and Brazil (N501Y, E484K, K417T). Chondramide C6 (9) showed highest BE towards GRP78 RBD. Molecular dynamics simulations were also performed for chondramides 1 and 2 against SARS-CoV-2 spike RBD of the Wuhan wild-type and the South African variant, respectively, where resulting complexes demonstrated dynamic stability within a 120-ns simulation time. Protein-protein binding experiments using HADDOCK illustrated weaker binding affinity for complexed chondramide ligands in the RBD against the studied host cell receptors. The chondramide derivatives in general possessed favorable pharmacokinetic properties, highlighting their potential as prototypic anti-COVID-19 drugs limiting viral attachment and possibly minimizing viral infection. Communicated by Ramaswamy H. Sarma
- 1 July 2021
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 84 (7) , 2053-2058
Catechol-Bearing Polyketide Derivatives from Sparticola junci
Sparticols A (1) and B (2), two catechol-bearing naphthalenedioxy derivatives, were isolated from the submerged culture of the Spanish broom inhabiting Dothideomycetes fungus, Sparticola junci. The structures of 1 and 2 were established by NMR spectroscopic analysis and high-resolution mass spectrometry. The 8S absolute configuration of their beta-hydroxy functionalities was determined by ECD-TDDFT. Both compounds exhibited inhibitory activity against Staphylococcus aureus with an MIC value of 66.6 mu g/mL. Polyketides 1 and/or 2 may be associated with pathways cascading to seco-spirodioxynapthalene derivatives.
- 1 July 2021
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 84 (7) , 2053-2058
Catechol-Bearing Polyketide Derivatives from Sparticola junci
Sparticols A (1) and B (2), two catechol-bearing naphthalenedioxy derivatives, were isolated from the submerged culture of the Spanish broom inhabiting Dothideomycetes fungus, Sparticola junci. The structures of 1 and 2 were established by NMR spectroscopic analysis and high-resolution mass spectrometry. The 8S absolute configuration of their beta-hydroxy functionalities was determined by ECD-TDDFT. Both compounds exhibited inhibitory activity against Staphylococcus aureus with an MIC value of 66.6 mu g/mL. Polyketides 1 and/or 2 may be associated with pathways cascading to seco-spirodioxynapthalene derivatives.
- 16 June 2020
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 39 (12) , 4316-4333
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
The novel coronavirus SARS-CoV2, the causative agent of the pandemic disease COVID-19, emerged in December 2019 forcing lockdown of communities in many countries. The absence of specific drugs and vaccines, the rapid transmission of the virus, and the increasing number of deaths worldwide necessitated the discovery of new substances for anti-COVID-19 drug development. With the aid of bioinformatics and computational modelling, ninety seven antiviral secondary metabolites from fungi were docked onto five SARS-CoV2 enzymes involved in viral attachment, replication, post-translational modification, and host immunity evasion infection mechanisms followed by molecular dynamics simulation and in silico ADMET prediction (absorption, distribution, metabolism, excretion and toxicity) of the hit compounds. Thus, three fumiquinazoline alkaloids scedapin C (15), quinadoline B (19) and norquinadoline A (20), the polyketide isochaetochromin D1 (8), and the terpenoid 11a-dehydroxyisoterreulactone A (11) exhibited high binding affinities on the target proteins, papain-like protease (PLpro), chymotrypsin-like protease (3CLpro), RNA-directed RNA polymerase (RdRp), non-structural protein 15 (nsp15), and the spike binding domain to GRP78. Molecular dynamics simulation was performed to optimize the interaction and investigate the stability of the top-scoring ligands in complex with the five target proteins. All tested complexes were found to have dynamic stability. Of the five top-scoring metabolites, quinadoline B (19) was predicted to confer favorable ADMET values, high gastrointestinal absorptive probability and poor blood-brain barrier crossing capacities.
- 16 June 2020
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 39 (12) , 4316-4333
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
The novel coronavirus SARS-CoV2, the causative agent of the pandemic disease COVID-19, emerged in December 2019 forcing lockdown of communities in many countries. The absence of specific drugs and vaccines, the rapid transmission of the virus, and the increasing number of deaths worldwide necessitated the discovery of new substances for anti-COVID-19 drug development. With the aid of bioinformatics and computational modelling, ninety seven antiviral secondary metabolites from fungi were docked onto five SARS-CoV2 enzymes involved in viral attachment, replication, post-translational modification, and host immunity evasion infection mechanisms followed by molecular dynamics simulation and in silico ADMET prediction (absorption, distribution, metabolism, excretion and toxicity) of the hit compounds. Thus, three fumiquinazoline alkaloids scedapin C (15), quinadoline B (19) and norquinadoline A (20), the polyketide isochaetochromin D1 (8), and the terpenoid 11a-dehydroxyisoterreulactone A (11) exhibited high binding affinities on the target proteins, papain-like protease (PLpro), chymotrypsin-like protease (3CLpro), RNA-directed RNA polymerase (RdRp), non-structural protein 15 (nsp15), and the spike binding domain to GRP78. Molecular dynamics simulation was performed to optimize the interaction and investigate the stability of the top-scoring ligands in complex with the five target proteins. All tested complexes were found to have dynamic stability. Of the five top-scoring metabolites, quinadoline B (19) was predicted to confer favorable ADMET values, high gastrointestinal absorptive probability and poor blood-brain barrier crossing capacities.